NOVAGENIX BIOANALYTICAL RAND D. CENT
Company Profile:
NOVAGENIX BIOANALYTICAL R AND D. CENT Company Introduction:
NOVAGENIX BIOANALYTICAL R AND D. CENT is a Turkish biotechnology company primarily focused on research and development in bioanalytical technologies. The company specializes in developing innovative solutions, products, and diagnostic tools within the biotechnology and life sciences sectors. Their activities include the creation of advanced technologies and applications for areas such as medical diagnostics, laboratory analysis, and research. They aim to contribute to scientific advancements and healthcare improvements through their R&D efforts.
Factory or Trader:
NOVAGENIX BIOANALYTICAL R AND D. CENT is primarily a factory/manufacturer. As an R&D Center, its core business involves the development and often the subsequent production of its own bioanalytical products and technologies, rather than solely trading products manufactured by others.
Enterprise Products
NOVAGENIX BIOANALYTICAL R&D CENT in Turkey primarily provides specialized bioanalytical research and development services rather than manufacturing or selling tangible products in the traditional sense. Their core offerings, which can be considered their "products" or "services sold," include:
Bioanalytical Method Development
Bioanalytical Method Validation
Bioanalysis of Study Samples
Pharmacokinetic (PK) Analysis
Toxicokinetic (TK) Analysis
Immunogenicity Testing
Biomarker Analysis
Biosimilar Studies
Drug-Drug Interaction Studies
In Vitro ADME Studies
Clinical Sample Analysis
Pre-clinical Sample Analysis
Consultancy Services
Business Registration Information:
Manager:
Phone:
E-mail:
Official Website:
Address:
Hacettepe University Teknokent 4th R&D Building Ground Floor No: Z04 Beytepe Mahallesi 06800 Çankaya / Ankara / TURKEY
This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.